EDESA BIOTECH, INC. Foreign Currency Transaction Loss, before Tax
EDESA BIOTECH, INC. (EDSA) reported Foreign Currency Transaction Loss, before Tax of $2.97 thousand for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-13.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:ForeignCurrencyTransactionLossBeforeTax · last filed 2022-05-13
- EDESA BIOTECH, INC. foreign currency transaction loss, before tax for the quarter ending 2022-03-31 was $2.97K, a 96.29% decline year-over-year.
- EDESA BIOTECH, INC. foreign currency transaction loss, before tax for the quarter ending 2021-12-31 was $3.33K, a 86.53% decline year-over-year.
- EDESA BIOTECH, INC. foreign currency transaction loss, before tax for the quarter ending 2021-03-31 was $80.03K.
- EDESA BIOTECH, INC. foreign currency transaction loss, before tax for the quarter ending 2020-12-31 was $24.73K.
- EDESA BIOTECH, INC. foreign currency transaction loss, before tax for fiscal 2021 was $13.02K, a 3457.92% increase from fiscal 2020.
- EDESA BIOTECH, INC. foreign currency transaction loss, before tax for fiscal 2020 was $366.00.
| Period end | Foreign Currency Transaction Loss, before Tax 3 month | Foreign Currency Transaction Loss, before Tax 6 month | Foreign Currency Transaction Loss, before Tax 12 month |
|---|---|---|---|
| 2022-03-31 | $2.97K 10-Q · filed 2022-05-13 | $364.00 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $3.33K 10-Q · filed 2022-02-14 | ||
| 2021-09-30 | $13.02K 10-K · filed 2021-12-28 | ||
| 2021-03-31 | $80.03K 10-Q · filed 2022-05-13 | $55.30K 10-Q · filed 2022-05-13 | |
| 2020-12-31 | $24.73K 10-Q · filed 2022-02-14 | ||
| 2020-09-30 | $366.00 10-K · filed 2021-12-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B |